Swedish Orphan Biovitrum AB (BIOVF)
42.80
0.00 (0.00%)
USD |
OTCM |
Oct 07, 16:00
Swedish Orphan Biovitrum Max Drawdown (5Y) : 41.60% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 41.60% |
| August 31, 2026 | 41.60% |
| July 31, 2026 | 41.60% |
| June 30, 2026 | 43.36% |
| May 31, 2026 | 47.36% |
| April 30, 2026 | 51.25% |
| March 31, 2026 | 51.25% |
| February 28, 2026 | 51.25% |
| January 31, 2026 | 51.25% |
| December 31, 2025 | 51.25% |
| November 30, 2025 | 51.25% |
| October 31, 2025 | 51.25% |
| September 30, 2025 | 51.25% |
| August 31, 2025 | 51.25% |
| July 31, 2025 | 51.25% |
| June 30, 2025 | 51.25% |
| May 31, 2025 | 51.25% |
| April 30, 2025 | 51.25% |
| March 31, 2025 | 51.25% |
| February 28, 2025 | 51.25% |
| January 31, 2025 | 51.25% |
| December 31, 2024 | 51.25% |
| November 30, 2024 | 51.25% |
| October 31, 2024 | 51.25% |
| September 30, 2024 | 52.96% |
| Date | Value |
|---|---|
| August 31, 2024 | 52.96% |
| July 31, 2024 | 52.96% |
| June 30, 2024 | 52.96% |
| May 31, 2024 | 52.96% |
| April 30, 2024 | 52.96% |
| March 31, 2024 | 52.96% |
| February 29, 2024 | 52.96% |
| January 31, 2024 | 52.96% |
| December 31, 2023 | 52.96% |
| November 30, 2023 | 52.96% |
| October 31, 2023 | 52.96% |
| September 30, 2023 | 52.96% |
| August 31, 2023 | 52.96% |
| July 31, 2023 | 52.96% |
| June 30, 2023 | 52.96% |
| May 31, 2023 | 52.96% |
| April 30, 2023 | 52.96% |
| March 31, 2023 | 52.96% |
| February 28, 2023 | 52.96% |
| January 31, 2023 | 52.96% |
| December 31, 2022 | 52.96% |
| November 30, 2022 | 52.96% |
| October 31, 2022 | 52.96% |
| September 30, 2022 | 52.96% |
| August 31, 2022 | 52.96% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Hansa Biopharma AB | 92.88% |
| BioArctic AB | -- |
| Diamyd Medical AB | 81.15% |
| BONESUPPORT HOLDING AB | 63.10% |
| BioInvent International AB | 97.62% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 1.001 |
| Beta (5Y) | 0.4652 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 32.98% |
| Historical Sharpe Ratio (5Y) | 0.1715 |
| Historical Sortino (5Y) | 0.2565 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 15.06% |